N-(pyridin-3-yl)-2-phenylbutanamides as androgen receptor modulators

Details for Australian Patent Application No. 2005310238 (hide)

Owner Merck & Co., Inc.

Inventors Kim, Yuntae; Meissner, Robert S.; Hanney, Barbara; Close, Joshua; Perkins, James J.; Musselman, Jeffrey; Duggan, Mark E.; Wang, Jiabing

Agent Spruson & Ferguson

Pub. Number AU-A-2005310238

PCT Pub. Number WO2006/060108

Priority 60/623,442 29.10.04 US

Filing date 25 October 2005

Wipo publication date 8 June 2006

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

C07D 213/02 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/060108 Priority application(s): WO2006/060108

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

24 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005310239-2-aminopyridine compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease

2005310231-Boron-containing molecular sieve CHA